Ignite Creation Date:
2025-12-25 @ 12:14 AM
Ignite Modification Date:
2025-12-25 @ 10:16 PM
Study NCT ID:
NCT00281658
Status:
COMPLETED
Last Update Posted:
2023-02-10
First Post:
2006-01-23
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Study In Women And Men With Metastatic Breast Cancer That Have Overexpression Of ErbB2
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-01-02
Start Date Type:
ACTUAL
Primary Completion Date:
2010-06-18
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-11-23
Completion Date Type:
ACTUAL
First Submit Date:
2006-01-23
First Submit QC Date:
None
Study First Post Date:
2006-01-25
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2011-05-05
Results First Submit QC Date:
None
Results First Post Date:
2011-06-01
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-02-09
Last Update Post Date:
2023-02-10
Last Update Post Date Type:
ACTUAL